Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533721) titled 'Ibuprofen vs Expectant Management for hsPDA in Preterm Infants: Retrospective Cohort' on April 5.
Study Type: Observational
Primary Sponsor: Shengjing Hospital
Condition:
Patent Ductus Arteriosus
Infant, Premature
Intervention:
Drug: Ibuprofen
Recruitment Status: Not recruiting
Date of First Enrollment: June 1, 2020
Target Sample Size: 541
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07533721
Published by HT Digital Content Services with permission from Health Daily Digest....